Filter by:
In 2017, in order to contribute to reflection on so-called "substance-free" addictions among adolescents, the French Monitoring Centre for Drugs and Drug Addiction (OFDT) integrated a new module on the use of various electronic devices with screens into its Survey on Health and Use on National Defence and Citizenship Day (ESCAPAD).
The epidemic of opioid overdose deaths in the United States highlights the issue of drug-related deaths.
This Théma report is devoted to the changes in the cannabis market in France, particularly in relation to the increase in the use of herbal cannabis.
This briefing paper describes the regulatory models that have been implemented since 2014 in the American states that have legalised cannabis, highlighting their differences and similarities. It also discusses the reform processes and common features of states that have legalised cannabis for medical and recreational use.
In 2018, two major international surveys Health Behaviour in School-aged Children (HBSC) and European School Project on Alcohol and other Drugs (ESPAD) were carried out simultaneously for the first time in France, using a unified scientific framework.
This summary covers the main contributions from a collective OFDT publication entitled "Drogues et addictions, données essentielles" issued in April 2019.
Since 1999, the OFDT has been quantifying the opinions and perceptions of the French population on drugs and related public policies through the EROPP survey (Survey on representations, opinions and perceptions regarding psychoactive drugs).
As a minority in specialised care services, French women presenting with addictions represent 23% and 18% of the public seen in specialised drug treatment centres (CSAPA) and harm reduction facilities (CAARUD) respectively.
In the wake of the 2017 findings, the year 2018 was marked by a sharp decline in cigarette and of roll-your-own tobacco sales in France's tobacconist network. However, a slight increase in other types of tobacco, less heavily taxed, can be seen, together with a likely increase in cross-border purchases.
This eight-page document provides the most relevant figures for measuring and providing a quick overview of drug-related phenomena.